1. Home
  2. ESRT vs PHAT Comparison

ESRT vs PHAT Comparison

Compare ESRT & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Empire State Realty Trust Inc.

ESRT

Empire State Realty Trust Inc.

HOLD

Current Price

$5.74

Market Cap

913.4M

Sector

Real Estate

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$12.08

Market Cap

894.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESRT
PHAT
Founded
2011
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
913.4M
894.0M
IPO Year
2012
2019

Fundamental Metrics

Financial Performance
Metric
ESRT
PHAT
Price
$5.74
$12.08
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
$6.35
$19.83
AVG Volume (30 Days)
1.2M
1.4M
Earning Date
04-29-2026
04-30-2026
Dividend Yield
2.49%
N/A
EPS Growth
N/A
42.72
EPS
0.01
N/A
Revenue
$768,270,000.00
$175,110,000.00
Revenue This Year
$4.26
$93.04
Revenue Next Year
$1.52
$58.91
P/E Ratio
$22.66
N/A
Revenue Growth
0.05
216.93
52 Week Low
$4.87
$3.69
52 Week High
$8.76
$18.31

Technical Indicators

Market Signals
Indicator
ESRT
PHAT
Relative Strength Index (RSI) 60.42 50.49
Support Level $4.87 $10.38
Resistance Level $7.04 $12.44
Average True Range (ATR) 0.18 1.03
MACD 0.02 -0.01
Stochastic Oscillator 90.91 64.24

Price Performance

Historical Comparison
ESRT
PHAT

About ESRT Empire State Realty Trust Inc.

Empire State Realty Trust Inc is a real estate investment trust (REIT) that owns and operates office, retail, and multifamily properties located in New York City, prominently in Manhattan. Its portfolio includes office and retail space as well as residential units. The company's objective is to maximize cash flow and total returns to its shareholders and to increase the value of the properties. Its reportable segments consist of a real estate segment and an Observatory segment. The majority of revenue is derived from the Real Estate segment, which includes all activities related to the ownership, management, operation, acquisition, redevelopment, repositioning and disposition of its traditional real estate assets.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: